Загрузка...
Combined Radionuclide Therapy and Immunotherapy for Treatment of Triple Negative Breast Cancer
Triple negative breast cancer (TNBC) is an aggressive subtype of the disease with poor clinical outcomes and limited therapeutic options. Immune checkpoint blockade (CP) has surged to the forefront of cancer therapies with widespread clinical success in a variety of cancer types. However, the percen...
Сохранить в:
| Опубликовано в: : | Int J Mol Sci |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8124136/ https://ncbi.nlm.nih.gov/pubmed/34063642 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22094843 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|